Implementing a standardised preoperative drug prophylaxis to reduce the incidence of postoperative nausea and vomiting in cardiac surgery patients: a prospective study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014275

Enrollment

200

Registered

2018-06-29

Start date

2016-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting (PONV)

Interventions

Group 1: Patient who underwent cardiac surgery and are extubated, will be interwieved on the first postoperative day. The will be questioned about postoperative nausea and vomiting, the Apfel-Score, N

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Voluntariness, performed cardiac surgery, volatile anaesthesia combined with an intraoperative drug prophylaxis.

Exclusion criteria

Exclusion criteria: TAVI (Transcatheter Aortic Valve Implantation), prolonged weaning, refusal, complications like second surgery

Design outcomes

Primary

Measure	Time frame
The current study aimed to investigate whether implementing an intraoperative drug prophylaxis leads to a lower PONV (postoperative nausea and vomiting) rate expected by the Apfel score in patients undergoing cardiac surgery. The survey is conducted on the first day after the operation by interviewing patient which are extubated.	—

Countries

Germany

Contacts

Public ContactAndreas Baumann

Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil

andreas.baumann@bergmannsheil.de02343023496

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 21, 2026